The UPF0444 transmembrane protein C12orf23 homolog B is a protein expressed in Xenopus laevis that belongs to the UPF0444 protein family. This protein is also known as transmembrane protein 263-B (tmem263-b) and is identified by the UniProt accession number Q5U4X2 . The "UPF" designation (Uncharacterized Protein Family) indicates that while the protein has been identified and sequenced, its precise biological function remains to be fully elucidated. The C12orf23 nomenclature suggests homology to a protein originally identified on human chromosome 12.
Calculations based on the amino acid composition reveal that the protein has a molecular mass of approximately 13,489.71 Daltons. This molecular weight is consistent with the expected size of a small transmembrane protein. The detailed amino acid weight contribution can be represented in the following table:
| Amino Acid | Count in Sequence | Individual Weight (Da) | Total Contribution (Da) |
|---|---|---|---|
| Alanine (A) | Multiple | 89.09 | Partial sum |
| Cysteine (C) | Multiple | 121.15 | Partial sum |
| Glycine (G) | Multiple | 75.07 | Partial sum |
| Valine (V) | Multiple | 117.15 | Partial sum |
| Others | Varying | Various | Remaining sum |
| Total | 114 | - | 13,489.71 |
The protein's molecular properties make it suitable for various biochemical and structural studies, with its relatively small size facilitating recombinant expression and purification.
The Recombinant Xenopus laevis UPF0444 transmembrane protein C12orf23 homolog B is typically produced in Escherichia coli expression systems . This bacterial expression system allows for efficient production of the protein in quantities suitable for research applications. The recombinant version commonly includes an N-terminal histidine tag (His-tag), which facilitates purification through affinity chromatography . The expression construct typically encompasses the full-length protein sequence (amino acids 1-114), providing a complete representation of the native protein structure.
Following expression in E. coli, the recombinant protein undergoes purification processes that typically yield preparations with greater than 90% purity as determined by SDS-PAGE analysis . The purified protein is commonly provided in lyophilized form, which enhances stability during shipping and storage. Quality control measures ensure that the final product maintains its structural integrity and biochemical properties for research applications.
As a member of the transmembrane protein family, the UPF0444 C12orf23 homolog B is presumed to span cellular membranes. Transmembrane proteins play crucial roles in cellular processes including signal transduction, transport of molecules, and maintenance of cellular structure. While the specific membrane localization of this protein has not been explicitly described in the search results, its classification as a transmembrane protein suggests integration within cellular membranes of Xenopus laevis.
The existence of both A and B homologs of this protein in Xenopus laevis (tmem263-a and tmem263-b) suggests potential gene duplication events . Furthermore, the identification of a human homolog, TMEM263 (transmembrane protein 263, gene ID 90488) , indicates evolutionary conservation across vertebrate species. This conservation suggests fundamental biological importance, as functionally significant proteins tend to be preserved across evolutionary distance.
While the specific function of UPF0444 transmembrane protein C12orf23 homolog B remains largely uncharacterized, its conservation across species and classification as a transmembrane protein suggest potential roles in:
Membrane organization and maintenance
Transport of ions or small molecules
Signal transduction or cellular communication
Structural roles in specific cellular compartments
Research into related transmembrane proteins may provide insights into its function, though direct experimental evidence for this specific protein's role remains limited in the current literature.
The recombinant version of this protein serves several purposes in molecular and cellular research:
As an antigen for antibody production against the native protein
For protein-protein interaction studies to identify binding partners
In structural biology investigations to determine three-dimensional conformation
As a standard for quantitative analyses of protein expression in Xenopus laevis tissues
The availability of purified recombinant UPF0444 transmembrane protein C12orf23 homolog B enables various experimental approaches that may elucidate its function:
| Experimental Approach | Potential Insights |
|---|---|
| Co-immunoprecipitation studies | Identification of interacting proteins |
| Cellular localization assays | Determination of subcellular distribution |
| Functional knockdown | Phenotypic effects of protein deficiency |
| Structural analysis | Three-dimensional configuration and binding domains |
| Comparative studies with homolog A | Functional divergence between paralogs |
These applications highlight the value of recombinant protein production for advancing our understanding of proteins with unknown functions.
Xenopus laevis appears to express two related proteins in this family: UPF0444 transmembrane protein C12orf23 homolog A (tmem263-a) and homolog B (tmem263-b) . While the search results provide limited information on homolog A, the presence of two paralogs suggests potential functional specialization following gene duplication events. Comparative analysis of these homologs could reveal insights into their respective biological roles and evolutionary history.
The human homolog, TMEM263 (transmembrane protein 263), is identified in the NCBI gene database (gene ID 90488) . While specific functional data about this human protein is not detailed in the search results, the evolutionary relationship between the Xenopus and human proteins suggests potential functional conservation. Research on human TMEM263 might provide comparative insights that could illuminate the function of the Xenopus protein.
KEGG: xla:495413
UniGene: Xl.57039
TMEM263 (formerly C12orf23) is a transmembrane protein with emerging evidence suggesting crucial roles in growth and bone development. While much remains to be characterized about this protein, studies in humans have demonstrated significant associations between TMEM263 and femoral neck bone mineral density (FN-BMD) . The protein appears to be correlated with osteoblast functional modules that impact bone mineral density by modulating bone-forming osteoblast activity .
Xenopus laevis serves as an excellent model organism for studying TMEM263 because:
Its phylogenetically intermediate position between aquatic vertebrates and land tetrapods provides evolutionary context for protein function conservation
The immune system and developmental biology of Xenopus is remarkably well-conserved yet allows researchers to distinguish species-specific adaptations from more fundamental conserved features
Xenopus embryos can be easily induced to breed in laboratory settings, making developmental studies highly accessible
The model allows for comprehensive analysis of protein expression changes during development, as demonstrated in large-scale proteomic studies that have successfully quantified nearly 4,000 proteins across developmental stages
Current evidence suggests TMEM263 may function through several molecular mechanisms:
Growth hormone pathway interaction: Protein-protein interaction studies have demonstrated that TMEM263 physically interacts with growth hormone 1 (GH1), suggesting it may act as a regulator in transport or signal transduction within growth pathways .
Ion channel regulation: TMEM263 has been identified as an interaction partner of potassium channel genes Slick and Slack, which are sodium-activated channels widely expressed in the central nervous system . This suggests potential roles in neuronal regulation or signaling.
Bone formation regulation: TMEM263 expression levels correlate with osteoblast functional modules that impact bone mineral density, indicating functional involvement in cartilage and bone formation processes .
The multifunctional nature of this protein makes it particularly valuable for developmental biology research using the Xenopus model system.
The study of TMEM263 expression during Xenopus development is best approached through a combination of proteomic and molecular techniques:
Quantitative proteomics using iTRAQ labeling: Isobaric tags for relative and absolute quantitation (iTRAQ) methodology has been successfully employed to monitor protein expression kinetics of Xenopus laevis embryos at multiple developmental stages . This approach can detect and quantify thousands of proteins simultaneously, making it ideal for tracking TMEM263 expression within the broader proteomic context.
Stage-specific western blotting: For targeted validation of expression patterns identified through proteomics, western blotting across developmental stages can confirm protein-level changes, as demonstrated for other developmentally regulated proteins like XCdc6 .
mRNA expression analysis: Complementing protein studies with transcript analysis provides insight into post-transcriptional regulation. Previous studies have detected mRNA expression of approximately 5,000 genes in Xenopus laevis early development (stages 2-33) .
Single-cell analysis approaches: Advanced proteomic technologies now enable protein expression studies in single zygotes, allowing for precise temporal resolution of expression changes during the earliest developmental stages .
When designing these experiments, researchers should consider the natural protein abundance distribution in Xenopus embryos, as detection sensitivity is strongly influenced by relative protein abundance and mass spectrometer limitations .
The Xenopus oocyte presents a powerful cellular model for studying TMEM263 function through several methodological approaches:
A limitation to consider is that variability in post-translational processing between oocytes can lead to functional differences in expressed proteins . Researchers should implement appropriate controls and sufficient biological replicates to account for this variability.
When designing loss-of-function studies for TMEM263 in Xenopus, researchers should consider:
Technique selection based on experimental timeline:
Morpholino antisense oligonucleotides for transient knockdown during early development
CRISPR/Cas9 genome editing for stable genetic knockout studies
Dominant-negative construct expression for pathway interference
Validation strategies for knockdown/knockout efficiency:
Western blotting to confirm protein depletion
qRT-PCR to assess transcript reduction
Immunohistochemistry to evaluate spatial expression changes
Developmental timing considerations:
Stage-specific requirements for TMEM263 function
Maternal contribution of TMEM263 that may mask early phenotypes
Critical windows for phenotypic assessment
Phenotypic analysis framework:
Rescue experiments to confirm specificity:
Co-injection of wild-type TMEM263 mRNA with knockdown reagents
Structure-function analysis through rescue with modified versions
Given TMEM263's potential roles in bone development and growth pathways, researchers should particularly focus on skeletal phenotypes and growth metrics when assessing loss-of-function effects.
Detecting low-abundance proteins like TMEM263 in Xenopus samples requires careful optimization of proteomic workflows. Based on computational modeling of experimental design for proteomics, several parameters significantly impact detection success:
Protein separation strategy:
Mass spectrometry detection optimization:
Sample loading considerations:
Dynamic range enhancement:
A simulated comparison of different experimental designs demonstrated that implementing protein separation and enhancing detection sensitivity should be prioritized before improving peptide separation or MS dynamic range when targeting comprehensive proteome coverage .
| Experimental Design Parameter | Initial Setting | Optimized Setting | Impact on Low-Abundance Detection |
|---|---|---|---|
| Protein Separation | None | Multiple fractions | High positive impact |
| MS Detection Sensitivity | 1 fmol | <0.1 fmol | High positive impact |
| Sample Load | 0.1 μg | >1 μg | High positive impact |
| MS Dynamic Range | 100-fold | >1,000-fold | Moderate impact (significant when combined with good sensitivity) |
As a transmembrane protein, TMEM263 presents particular challenges for recombinant expression and proper folding. Researchers can implement several strategies to address these challenges:
Expression system optimization:
While E. coli systems are common for recombinant protein production, transmembrane proteins often require eukaryotic expression systems
Xenopus oocytes present an excellent native-like environment for expression and functional studies of transmembrane proteins
Insect cell systems (Sf9, Sf21) may provide alternatives with high expression yields
Membrane protein solubilization approaches:
Careful detergent selection based on TMEM263's predicted structure
Screening of multiple detergent classes (maltosides, glucosides, phosphocholines)
Consideration of lipid-like peptides or nanodiscs for maintaining native-like membrane environment
Folding assessment methods:
Circular dichroism spectroscopy to evaluate secondary structure content
Limited proteolysis to assess conformational stability
Functional assays to confirm proper folding through activity measurements
Protein engineering strategies:
Fusion tags that enhance solubility while minimizing interference with folding
Truncation constructs to identify stable domains if full-length expression is problematic
Glycosylation site engineering to improve folding efficiency in eukaryotic systems
When working with Xenopus oocytes specifically, researchers should note that while they perform many post-translational modifications efficiently, occasional differences from native cells might affect proper folding of certain proteins . Including positive controls with known folding characteristics can help distinguish experimental issues from protein-specific challenges.
When faced with contradictory findings regarding TMEM263 protein interactions, researchers should implement a systematic approach to resolution:
Evaluate methodological differences:
Different interaction detection methods have varying sensitivities and limitations
Co-immunoprecipitation followed by mass spectrometry (the method that identified TMEM263 interaction with GH1 ) typically detects stable interactions
Proximity labeling approaches may capture more transient interactions
Yeast two-hybrid systems can detect direct binary interactions but may miss complex-dependent interactions
Consider cellular context variations:
Interactions documented in human systems may differ from those in Xenopus
Developmental stage-specific interactions may not be conserved across all contexts
Subcellular localization differences can affect interaction opportunities
Validate interactions through orthogonal approaches:
Establish interaction hierarchies:
Primary vs. secondary interactions
Direct vs. indirect associations within protein complexes
Determine biological significance through functional impact assessment
The TMEM263 interaction with growth hormone 1 was identified through co-immunoprecipitation followed by mass spectrometry , while interaction with potassium channels was established through different methodologies. Validating these interactions specifically in the Xenopus system would be a valuable contribution to understanding TMEM263 function in this model organism.
Analysis of TMEM263 expression across developmental stages requires robust statistical approaches tailored to time-series proteomic data:
Normalization strategies:
Global normalization methods may be insufficient for developmental proteomics
Stage-specific internal standards should be considered
Normalization to housekeeping proteins with stable expression across development
Time-series analysis methods:
Clustering approaches to identify proteins with similar expression patterns
Principal component analysis to identify major sources of variation
Differential expression analysis with time as a continuous variable
Multiple testing correction:
Developmental proteomics involves thousands of proteins measured across multiple timepoints
Appropriate false discovery rate (FDR) control is essential
Methods like Benjamini-Hochberg or more stringent Bonferroni correction depending on discovery vs. validation goals
Correlation analysis with phenotypes:
Correlation of TMEM263 expression changes with developmental milestones
Integration with morphological or functional measurements
Pathway analysis to identify co-regulated networks
In previous large-scale Xenopus developmental proteomics studies, researchers successfully quantified expression changes of nearly 4,000 proteins during early development, organizing them into expression pattern clusters . Similar approaches can be applied specifically to TMEM263 and its potential interaction partners to identify coordinated expression changes with functional significance.
CRISPR/Cas9 genome editing technology offers powerful approaches for elucidating TMEM263 function in Xenopus:
Precise genetic knockout models:
Complete gene knockout to assess developmental consequences
Domain-specific modifications to determine structure-function relationships
Conditional knockout strategies to bypass early developmental requirements
Knockin approaches for functional studies:
Endogenous tagging for accurate localization and interaction studies
Reporter gene fusions to track expression dynamics in living embryos
Introduction of human variants to assess evolutionary conservation of function
High-throughput functional screening:
Multiplex CRISPR targeting of TMEM263 pathway components
Combinatorial editing to assess genetic interactions
Saturation mutagenesis of regulatory regions to map expression control elements
Disease model development:
When implementing CRISPR approaches in Xenopus, researchers should consider the tetraploid nature of Xenopus laevis, which may require targeting multiple alleles to achieve complete loss of function. Xenopus tropicalis, being diploid, may offer advantages for certain genetic studies while maintaining the benefits of the Xenopus model system.
A comprehensive multi-omics approach would significantly advance understanding of TMEM263 function:
Integrated genomics, transcriptomics, and proteomics:
Correlation of genetic variation with expression changes
Analysis of post-transcriptional regulation through RNA-protein comparisons
Identification of regulatory networks controlling TMEM263 expression
Proteomics and interactomics integration:
Temporal mapping of TMEM263 protein interaction networks across development
Correlation of interaction dynamics with functional outcomes
Identification of protein complexes and their developmental regulation
Metabolomics correlation:
Association of TMEM263 expression with metabolic changes during development
Identification of biochemical pathways influenced by TMEM263 function
Metabolic consequences of TMEM263 dysfunction
Structural biology integration:
Mapping of interaction interfaces identified through proteomics onto structural models
Structure-guided hypothesis generation about molecular mechanisms
Rational design of experimental probes based on structural insights
Previous large-scale studies have already established methodologies for quantitative proteomics of Xenopus laevis embryos, successfully measuring expression kinetics of 3,983 proteins during early development . Expanding this approach to specifically focus on TMEM263 and its interaction network would provide unprecedented insight into its developmental functions.